It’s Pop Quiz Friday 9/7! Let’s See if You Get It Right!
A patient on sorafenib for renal cancer asks what side effect she is most likely to experience?
A.). Hypertrichosis
B.) Nevi changes
C.) Q-T prolongation
D.) Cystitis after the first month
E.) Redness and tender blisters at sites of pressure on the hands and feet
To find out the correct answer and read the explanation click here
Brought to you by our Brand …
A patient on sorafenib for renal cancer asks what side effect she is most likely to experience?
A.). Hypertrichosis
B.) Nevi changes
C.) Q-T prolongation
D.) Cystitis after the first month
E.) Redness and tender blisters at sites of pressure on the hands and feet
To find out the correct answer and read the explanation click here
Brought to you by our Brand … Continue reading "It’s Pop Quiz Friday 9/7! Let’s See if You Get It Right!"
One of the biggest issues in dermatology training over the last several years has been the change to the “Exam of the Future” format. The ABD has been applauded for moving away from the older system of boards and in-service exams by having the required components for board certification take place sequentially over the course of residency with the CORE and APPLIED exams. I arrived at my progra … 
In an informative 20-minute session on hair loss in skin of color patients,
Dr. Valerie Callender focused on how structural differences in afrocentric hair and cultural haircare practices contribute to the high prevalence of alopecia in African American women in particular.
*Clinical pearls* from this session are bolded, underlined, and marked with asterisks.
Dr. Callender started her lect … 
In Part II of our series about perception of dermatologists, Dr. Angelo Landriscina explores how dermatology is viewed by physicians in other specialties, and how it might affect patient care. Be sure not to miss “Perceptions in Dermatology Series – Part 1: How Does the Public View Dermatology?”.
Once I learned about the data showing how the lay public views dermatology, I couldn’t he … 
Treatment of this condition with IL-17 blockade has been shown to:
A) Increase the risk of Reversible Posterior Leukoencephalopathy Syndrome
B) Worsen pre-existing multiple sclerosis
C) increase risk for mucosal candidal infections
D) Cause hepatic fibrosis with long term use
To find out the correct answer and read the explanation click here. …